Glyburide Tablet
Product Images NDC 51655-659

3 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 51655-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyburide-structure (Glyburide Structure)

Glyburide-structure (Glyburide Structure)
Chemical structure diagram of glyburide, showing its molecular components including aromatic rings, chloro and methoxy substituents, sulfonylurea moiety, and cyclohexyl group.*
FDA Label Image
FDA Label Image

Label (51655 659 52 Rev B 05 24 Nhc)

Label (51655 659 52   Rev B 05 24 Nhc)
Label for GLYBURIDE Tablets USP 2.5 mg in a bottle of 30 tablets by Northwind Health Company, LLC. It includes storage instructions to keep at 20°-25°C (68°-77°F) with protection from light, and warnings to keep out of reach of children and to keep the container tightly closed. The label also notes it is a prescription drug (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.